HMVYX
Price
$18.42
Change
+$0.01 (+0.05%)
Updated
Dec 26 closing price
Net Assets
1.16B
MVCAX
Price
$30.48
Change
-$0.00 (-0.00%)
Updated
Dec 26 closing price
Net Assets
16.83B
Interact to see
Advertisement

HMVYX vs MVCAX

Header iconHMVYX vs MVCAX Comparison
Open Charts HMVYX vs MVCAXBanner chart's image
Hartford MidCap Value Y
Price$18.42
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets1.16B
MFS Mid Cap Value A
Price$30.48
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets16.83B
HMVYX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
HMVYX vs. MVCAX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVYX is a Buy and MVCAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.8B vs. HMVYX (1.16B). MVCAX pays higher dividends than HMVYX: MVCAX (0.83) vs HMVYX (0.77). HMVYX was incepted earlier than MVCAX: HMVYX (25 years) vs MVCAX (24 years). MVCAX (1.00) is less costly to investors than HMVYX (0.87). HMVYX is a more actively managed with annual turnover of: 132.00 vs. MVCAX (24.00). MVCAX has a lower initial minimum investment than HMVYX: MVCAX (1000) vs HMVYX (250000). HMVYX annual gain was more profitable for investors over the last year : 2.00 vs. MVCAX (-1.74). MVCAX return over 5 years is better than : 23.93 vs. HMVYX (15.19).
HMVYXMVCAXHMVYX / MVCAX
Total Expense Ratio0.870.9988%
Annual Report Gross Expense Ratio0.871.0087%
Fund Existence25 years24 years-
Gain YTD3.020-0.652-463%
Front LoadN/A6%-
Min. Initial Investment250000100025,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.16B16.8B7%
Annual Yield % from dividends0.770.8393%
Returns for 1 year2.00-1.74-115%
Returns for 3 years13.3813.9896%
Returns for 5 years15.1923.9363%
Returns for 10 years29.0472.8640%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RERE5.350.07
+1.33%
ATRenew
BRNS0.70N/A
+0.38%
Barinthus Biotherapeutics plc
KMX39.270.09
+0.23%
CarMax
RMR15.10-0.02
-0.13%
RMR Group (The)
APO148.52-0.33
-0.22%
Apollo Global Management